Abstract
Aims: To demonstrate how Q‐learning, a novel data analysis method, can be used with data from a sequential, multiple assignment, randomized trial (SMART) to construct empirically an adaptive treatment strategy (ATS) that is more tailored than the ATSs already embedded in a SMART. Method: We use Q‐learning with data from the Extending Treatment Effectiveness of Naltrexone (ExTENd) SMART ( N = 250) to construct empirically an ATS employing naltrexone, behavioral intervention, and telephone disease management to reduce alcohol consumption over 24 weeks in alcohol dependent individuals. Results: Q‐learning helped to identify a subset of individuals who, despite showing early signs of response to naltrexone, require additional treatment to maintain progress. Conclusions: Q‐learning can inform the development of more cost‐effective, adaptive treatment strategies for treating substance use disorders.
Funding Information
  • National Institutes of Health (R01‐MH‐080015, R03‐MH‐097954, R01‐AA‐014851, P01‐AA016821, RC1‐AA‐019092, R01‐DA‐039901, P50‐DA‐039838, P50‐DA‐010075, R01‐HD‐073975, and U54‐EB020404)

This publication has 45 references indexed in Scilit: